AstraZeneca vaccine: Most Australian recipients report some kind of reaction

Meanwhile Europe douses concern over increased thrombotic events with the COVID-19 vaccine, except for two rare types

About three out of four Australian recipients of AstraZeneca’s COVID-19 vaccine have experienced at least one adverse event, most commonly fatigue or headaches, new data show.

In addition, some 2.4% of the first 4000 recipients sought medical advice after getting their first dose of the adenovirus vector vaccine, the surveillance reveals.

The release of the first detailed safety information on Australia’s rollout of the vaccine comes as Europe grapples with concern over its links to thrombosis, with a review failing

Latest

Trending